Results 121 to 130 of about 4,279 (197)

Dalbavancin [PDF]

, 2020
openaire   +1 more source

Breaking Down Barriers: CorA Effectively Targets Staphylococcal Biofilms in Vitro and in Vivo. [PDF]

ChemMedChem
De Benedetti S, Kirilov NK, Zeng H, Ade C, Bodenstein I, Förster M, Abdel-Wadood N, Aljohmani A, Krasteva-Christ G, Yildiz D, Junker S, Khalid SJ, Rox K, Schrey H, Große M, Schiefer A, Becker SL, Pfarr K, Hoerauf A, Bischoff M, Müsken M, Schneider T.   +21 more
europepmc   +1 more source

Dalbavancin dosing in a severely underweight woman with prosthetic valve endocarditis: the critical role of proactive therapeutic drug monitoring. [PDF]

J Antimicrob Chemother
Barco A, Cattaneo D, Cusato J.
europepmc   +1 more source

Integrating Functional Response and Target Binding for Mechanism-Centered Drug Screening by High-Mass MALDI-MS. [PDF]

ACS Cent Sci
Tan C, Gao Y, Buggert M, Zhou Y, Zenobi R.   +4 more
europepmc   +1 more source

Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial.

JAMA Netw Open
Lodise TP, Turner NA, Hamasaki T, Fishbane N, Ghazaryan V, Wall A, Ge L, Wu Q, Zeng L, Riccobene T, Patel R, Zaharoff S, Rappo U, Evans S, Fowler VG, Chambers HF, Holland TL, Antibacterial Resistance Leadership Group.   +17 more
europepmc   +1 more source

Improving Access to Outpatient Antibiotic Therapy: Addition of Dalbavancin to a County Hospital Formulary for Complicated Staphylococcus aureus Infections. [PDF]

Cureus
Butt S, Tieman M, Kressel AB, Weaver B, Kays M.   +4 more
europepmc   +1 more source

Hyaluronic Acid-Based Hydrogel Coating Does Not Affect Bone Apposition at the Implant Surface in a Rabbit Model [PDF]

core   +1 more source

Predicting prolonged dalbavancin exposure using machine learning: a validated strategy for individualized redosing. [PDF]

Antimicrob Agents Chemother
Sayadi H, Gregoire M, Fromage Y, Ksentini M, Labriffe M, Monchaud C, Codde C, Faucher J-F, Boutoille D, Marquet P, Woillard J-B.   +10 more
europepmc   +1 more source

Monthly dalbavancin dosing for suppressive therapy: a pharmacokinetic estimation analysis and case series. [PDF]

Antimicrob Agents Chemother
Kufel WD, Tudahl K, Hutson P, Mahapatra R, Rose W, Volk C.   +5 more
europepmc   +1 more source

Long-Term Therapy with Long-Acting Lipoglycopeptide Antibiotics in the Treatment of Cardiovascular Prosthetic Infections: A Systematic Review. [PDF]

Antibiotics (Basel)
Gavaruzzi F, Granata G, Capone A, Chinello P, Cicalini S.   +4 more
europepmc   +1 more source